OPEN CFDA 93.270 ↗ Competitive Cooperative Agreement Hard ~100h to apply

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

🏛 Centers for Disease Control - NCHHSTP

⏰ Deadline
Dec 9, 2026 in 179 days
📊 Total program funding
$450M
🎯 Expected awards
60 recipients
📅 Fiscal Year
FY 2027
📍 Scope
National

Can you apply?

This grant is for state and territorial health departments and large city health departments engaged in viral hepatitis prevention and surveillance. Eligible applicants must serve jurisdictions with significant viral hepatitis burden and capacity to establish integrated surveillance, testing, and prevention programs.

Eligible activities include hepatitis A, B, and C outbreak response; disease surveillance and registry development; case investigations; and data-to-care coordination. Programs must address testing, treatment integration, and elimination planning in high-impact settings.

The grant supports two required components (outbreak response/surveillance and planning/partnerships) plus two optional components (testing/treatment/prevention and perinatal hepatitis C). Both state and territorial health departments and designated large city health departments may apply.

Eligible applicants
Check your eligibility — what type of organization are you?

Key dates

  1. Jun 9, 2026 Applications open
  2. Dec 9, 2026 Application deadline in 179 days
  3. Apr 1, 2027 Award announced
  4. May 1, 2027 Project start

Program description

This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings. 

This multi-component NOFO includes two required components and two optional components: 

  • Component 1: Outbreak Response and Surveillance (Required) 

  • Component 2: Planning, Partnerships, and Promotion (Required) 

  • Component 3: Testing, Treatment, and Prevention (Optional) 

  • Component 4: Perinatal Hepatitis C Program (Optional) 

This NOFO is alignment with CDC priorities. 

Who can apply

Eligible applicants

How to apply

Application links

Key dates & requirements

  • 🧾 Budget narrative required. Free budget template →
  • 📅 Expected award date: Apr 1, 2027
  • 🚀 Project start date: May 1, 2027

Required documents

  • SF-424 (Application for Federal Assistance)
  • Project Narrative/Statement of Work
  • Budget and Budget Justification
  • Organizational Capacity Statement
  • Hepatitis B and C Disease Epidemiology Data
  • Letters of Support from Partner Organizations
  • Health Department Organizational Chart and Staffing Plan

Program contact

Funding track record

No recent recipient data available for CFDA 93.270 in our database.

This can happen for newer programs, programs that use non-standard award types (loans, direct payments, fellowships), or those funded through sub-agencies under different codes.

Search this CFDA directly on USAspending.gov →

Funding history

Annual funding for this program — Federal obligations (CFDA 93.270). How funding has trended year over year.

2024 $25,387,623
2025 $22,075,947
2026 est. $22,000,000

FAQ

Who can apply for this grant?

State health departments, territorial health departments, and large city health departments are eligible. Your jurisdiction must have capacity for integrated viral hepatitis surveillance and prevention programs.

What are the deadline and typical funding amounts?

The deadline is December 9, 2026. Specific award amounts vary by jurisdiction and component selection; the total funding pool is $450 million across all awards.

What activities does this grant fund?

Viral hepatitis surveillance, outbreak response, disease registry development, hepatitis B/C testing expansion, treatment integration, and perinatal hepatitis C programs.

Is cost-sharing required?

No. This is a fully funded cooperative agreement with no cost-sharing requirement.

Can I apply for just one component?

You must include Components 1 and 2 (required). Components 3 and 4 are optional and can enhance your application competitiveness.

💡 Tips for applicants

  • Emphasize existing viral hepatitis burden data and surveillance gaps your jurisdiction faces. Use epidemiologic data to justify all proposed activities.
  • Clearly describe partnerships with clinics, labs, and community organizations. Show how agencies will coordinate testing, treatment, and case management.
  • Address all required components thoroughly. Optional components should fill gaps or expand reach but shouldn't replace core surveillance and planning work.
  • Develop realistic timelines for disease registry implementation and data matching. Budget sufficient staff for case investigations and data-to-care activities.
  • Align your elimination planning with CDC national hepatitis C and B elimination strategies. Show how your program contributes to national targets.

⚠️ Common mistakes

Weak documentation of current viral hepatitis epidemiology or surveillance capacity. Vague partnership commitments without memoranda of understanding or letters of support. Insufficient detail on how testing and treatment will integrate across high-impact settings.

Similar grants

Source: Grants.gov · FY 2027 · Last updated Jun 10, 2026

179 days left Dec 9, 2026
Apply →